Humacyte Announces Symvess® Contract with U.S. Department of Veterans Affairs

Humacyte, Inc. has announced that its acellular tissue engineered vessel, Symvess, is now under contract with the Strategic Acquisition Center of the U.S. Department of Veterans Affairs, making it accessible to 170 VA hospitals. The contract enhances the availability and visibility of Symvess in the VA healthcare system.